6OVA Stock Chart & Stats
€4.04
€0.18(4.46%)
At close: 4:00 PM EDT
€4.04
€0.18(4.46%)
Day’s Range― - ―
52-Week Range€4.00 - €8.75
Previous CloseN/A
Volume0.00
Average Volume (3M)44.00
Market Cap
€268.18M
Enterprise Value€333.76
Total Cash (Recent Filing)€121.27M
Total Debt (Recent Filing)€2.60M
Price to Earnings (P/E)56.9
Beta0.49
Next Earnings
Aug 06, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding63,414,160
10 Day Avg. Volume17
30 Day Avg. Volume44
Financial Highlights & Ratios
PEG Ratio1.48
Price to Book (P/B)2.08
Price to Sales (P/S)5.09
P/FCF Ratio70.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.91Price Target Upside95.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.17
Revenue Forecast (FY)€82.11M
Bulls Say, Bears Say
Bulls Say
High Profitability MarginsA high gross margin (~74.8%) and solid EBITDA margin (~20.3%) reflect scalable, software-driven economics and pricing power. These durable margins support continued investment in product and customer success, provide a cushion in downturns, and enable operating leverage as recurring revenue expands.
Very Low LeverageA near-zero debt-to-equity ratio (~0.01) gives Vitalhub significant financial flexibility. Low leverage reduces refinancing and interest risks, preserves cash for R&D or integrations, and allows the company to pursue bolt-on M&A or absorb short-term shocks without undermining operations.
Recurring Revenue ModelA revenue mix dominated by subscriptions, maintenance, and services creates predictable, recurring cash flows and high customer retention typical in healthcare IT. That stability enhances revenue visibility, supports long-term planning, and enables repeatable upsell and cross-sell economics over time.
Bears Say
Weak Near-Term Cash ConversionOperating cash flow of only ~0.11x net income indicates weak near-term cash conversion, likely due to working-capital timing or integration costs. If persistent, this constrains internally generated funds for growth or acquisitions and increases reliance on external financing despite reported profitability.
Moderating Margins / Moderate Net MarginWhile gross and EBITDA margins remain solid, the downtrend in gross margin and a modest net margin (~6.1%) limit earnings leverage. Continued margin erosion or adverse product mix shifts could cap free cash flow generation and reduce the firm's ability to reinvest profitably over the medium term.
Modest ROE Vs Scaled Equity BaseROE around ~3.0% versus historical peaks suggests earnings haven't kept pace with a materially larger equity base, possibly from equity-financed acquisitions or dilution. Sustained low ROE implies weaker capital efficiency and may pressure long-term shareholder returns absent margin or growth improvements.
Vitalhub News
6OVA FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was €4.00 and its highest was €8.75 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is €268.18M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is Aug 06, 2026 which is in 4 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on May 07, 2026. The company reported €0.025 earnings per share for the quarter, missing the consensus estimate of €0.037 by -€0.012.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.04.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,414,160 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of €0.025 in its last earnings report, missing expectations of €0.037. Following the earnings report the stock price went up 2.893%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in DE:6OVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€7.91 (95.89% Upside)
€7.91 (95.89% Upside)
Blogger Sentiment
Bullish
DE:6OVA Sentiment 100%
Sector Average 65%
Sector Average 65%
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
51.17%
Trailing 12-Months
Company Description
Vitalhub
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
6OVA Stock 12 Month Forecast
Average Price Target
€7.91
▲(95.89% Upside)
Technical Analysis
Diagnos
―
kneat.com
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―